Dr. Grace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Longwood Ave
Childrens Hospital Boston Karp 8
Boston, MA 02115Phone+1 617-355-6000- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
- The Warren Alpert Medical School of Brown UniversityClass of 2003
Certifications & Licensure
- MA State Medical License 2006 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP Start of enrollment: 2013 Aug 01
- Pyruvate Kinase Deficiency Natural History Study Start of enrollment: 2013 Dec 01
- A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency Start of enrollment: 2015 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsThe Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design.Rachael F Grace, Eduard J van Beers, Joan-Lluis Vives Corrons, Bertil Glader, Andreas Glenthøj, Hitoshi Kanno, Kevin H M Kuo, Carl Lander, D Mark Layton, Dagmar Pospíŝ...> ;BMJ Open. 2023 Mar 23
- 5 citationsUpdates and advances in pyruvate kinase deficiency.Neeti Luke, Kirsty Hillier, Hanny Al-Samkari, Rachael F Grace> ;Trends in Molecular Medicine. 2023 May 1
- 3 citationsEarly-onset reduced bone mineral density in patients with pyruvate kinase deficiency.Hanny Al-Samkari, Rachael F Grace, Andreas Glenthøj, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H M Kuo, D Mark Layton, Marta Morado Arias, Vip Viprak...> ;American Journal of Hematology. 2023 Mar 1
- Join now to see all
Abstracts/Posters
- A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in ChildrenRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Characterization of the Severe Phenotype of Pyruvate Kinase DeficiencyRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comorbidities and Complications in Adults with Pyruvate Kinase DeficiencyRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Special Education Session on ASH Clinical Practice Guidelines on Immune Thrombocytopenia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- Mitapivat Produces Durable Hemoglobin Responses in Patients with Pyruvate Kinase DeficiencyDecember 11th, 2021
- More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 5th, 2021
- Mitapivat Elicits Positive Response in Pyruvate Kinase DeficiencySeptember 4th, 2019
- Join now to see all
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Boston Children's HospitalBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: